Ganjei James Kelly
SEC CIK 1767300 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INMB | Inmune Bio, Inc. | Dir | 17.8K | — | — | 1 | 2022-03-22 | 2022-03-22 |
Most active insiders at INMB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Juda Scott | Dir | — | — |
| 2 | Lowdell Mark William | CSO | — | — |
| 3 | Moss David J | CEO, Dir | — | — |
Ganjei James Kelly made no open-market trades at INMB in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-23 | 2022-03-22 | INMB | Inmune Bio, Inc. | Ganjei James Kelly | Dir | A - Grant | $8.43 | +17.8K | 17.8K | New | +$150.0K |
Purchase Sale Sale after option exercise All abbreviations